PVP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PVP Ventures Ltd has signed binding agreements to acquire a 52% stake in Biohygea Global Private Limited, which operates diagnostic centers under the brand name Medilabs. The deal is a mix of primary and secondary share purchases, with PVP planning to increase its stake further over the coming years. Medilabs is a Chennai-based, NABL-accredited diagnostic company founded in 2014, offering pathology, radiology, CT imaging, and over 1,500 tests, with a strong presence in Tamil Nadu and plans to expand into Tier 2 and Tier 3 cities. The acquisition aligns with PVP's strategy of transforming from a realty company into a global healthcare services platform, funded by expected cash flows of over ₹1,500 crore from legacy real estate developments over the next six years. The diagnostics focus areas include fetal medicine, genomics, and oncology testing.
This is a strategic pivot for PVP from real estate into healthcare services, which could reshape its business profile and long-term growth story. Investors should watch for further stake increases, integration progress, and how the ₹1,500 crore realty cash flows are deployed into healthcare acquisitions.